7 September 2011
Government Response to Clinical Trials Report Welcomed
The Government’s response to the recently published Health Select Committee Report into Clinical Trials has been
welcomed by Medicines New Zealand.
“As the industry association representing innovative pharmaceutical companies in New Zealand we strongly support the
Government’s commitment to improving New Zealand's clinical trials environment,” Medicines New Zealand General Manager
Kevin Sheehy says
“We are encouraged to see Health Minister Tony Ryall outline how the ethics committee approval process will be
streamlined and simplified over the next 10 months through the following steps:
• more comprehensive procedural rules;
• internationally-competitive decision making timelines for ethics committees;
• shorter, simpler application forms; and
• an easier application system online.
“We are however disappointed that the Government does not intend to follow the recommendation to create a formal working
group with industry to provide further input to the implementation of the report’s recommendations,” Mr Sheehy says.
“We welcome the changes aimed at ensuring the ethics committees are more efficient and transparent as this will improve
New Zealand’s environment for clinical research while preserving the ability to ensure patients’ safety and respect for
“The changes will help New Zealand become acknowledged as a high quality destination for research investment,” Mr Sheehy